Dr Reddy’s Sells North American Rights For Celecoxib Oral Solution
As Company Partners With BioDelivery Sciences For Elyxyb
India’s Dr Reddy’s has sold the US and Canadian rights to its 25mg/ml Elyxyb (celecoxib) oral solution to US-based BioDelivery Sciences International, for an upfront payment of $6m, followed by $9m within one year from closing the deal.
